These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22350116)

  • 1. Outcome of photodynamic therapy in choroidal neovascularization due to pathologic myopia and related factors.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Int Ophthalmol; 2012 Apr; 32(2):119-25. PubMed ID: 22350116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
    Hussain N; Khanna R; Das T; Narayanan R; Sunday OT; Bansal AG; Reddy R
    Indian J Ophthalmol; 2008; 56(6):465-8. PubMed ID: 18974516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
    Costagliola C; Campa C; Incorvaia C; Parmeggiani F; Menzione M; Della Corte M; Rinaldi M; Romano M; Semeraro F
    Eur J Ophthalmol; 2008; 18(6):955-9. PubMed ID: 18988168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
    Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hara W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2008 Mar; 145(3):518-526. PubMed ID: 18207125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy.
    Maár N; Ergun E; Luksch A; Stur M
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1262-6. PubMed ID: 16538450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term study of photodynamic therapy with verteporfin for choroidal neovascularization at the edge of chorioretinal atrophy in pathologic myopia.
    Pece A; Milani P; Isola V; Pierro L
    Ophthalmologica; 2011; 225(3):161-8. PubMed ID: 21212705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
    Ergun E; Heinzl H; Stur M
    Am J Ophthalmol; 2004 Sep; 138(3):434-8. PubMed ID: 15364227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
    Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
    Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A; Vadalà M; Isola V; Matranga D
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.
    Gelisken F; Inhoffen W; Hermann A; Grisanti S; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):926-30. PubMed ID: 15258776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy in highly myopic eyes with choroidal neovascularization: 5 years of follow-up.
    Coutinho AM; Silva RM; Nunes SG; Cachulo ML; Figueira JP; Murta JN
    Retina; 2011 Jun; 31(6):1089-94. PubMed ID: 21358463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy in subfoveal and juxtafoveal myopic choroidal neovascularization: a 10-year retrospective analysis.
    Varano M; Iacono P; Giorno P; Chiaravalloti A; Parravano M
    Ophthalmologica; 2014; 231(4):204-10. PubMed ID: 24481122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization.
    Tan CS; Chew MC; Lim TH
    Eye (Lond); 2014 Jan; 28(1):17-22. PubMed ID: 24051405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
    Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
    Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study.
    Costa RA; Williams GA;
    Retina; 2006 Sep; 26(7):757-64. PubMed ID: 16963848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of photodynamic therapy for subfoveal choroidal neovascularization with pathologic myopia.
    Giansanti F; Virgili G; Donati MC; Giuntoli M; Pieretti G; Abbruzzese G; Menchini U
    Retina; 2012 Sep; 32(8):1547-52. PubMed ID: 22481476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.